drugset / Trial / NCT04011124
A Drug-drug Interaction Trial of Rifampicin Pharmacokinetics Effect on Fluzoparib
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of the study was to assess the effect of repeated oral doses of Rifampicin on the pharmacokinetic profile of a single dose of Fluzoparib. The secondary objective of the study was to assess the safety of Fluzoparib given alone versus Fluzoparib coadministered with Rifampicin.
Timeline
- Start
- 2019-07-24
- Primary completion
- 2019-09-16
- Completion
- 2019-09-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluzoparib | Small molecule | — | — |
| Subject | Rifampin | Small molecule | — | Oral |
Indications
No indication recorded.